Orasure Technologies Inc.
Bethlehem, PA Doing business as Orasure
- UEI
- Y79RWFLHWDM6
- CAGE
- 0PNX6
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Orasure Technologies Inc.
Y79RWFLHWDM6
- Diversigen, Inc. HAG3EPAFEDB4
- DNA Genotek Inc. MQMPSZXBJRC8
- Sherlock Biosciences, Inc. Z1K6AV77QHV5
-
Orasure Technologies Inc.
Y79RWFLHWDM6
- SAM.gov registration date
- Physical address
- 220 E 1st St, Bethlehem, PA 18015, USA
- Website
- orasure.com
- Founded
- 1987
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 8511361010 ! Control kit,hepatit | Medical Supply Chain | $25 | |
| 8511363238 ! Control kit,hepatit | Medical Supply Chain | $50 | |
| 8511352194 ! Control kit,hepatit | Medical Supply Chain | $25 | |
| 8511354619 ! Control kit,hepatit | Medical Supply Chain | $25 | |
| 8511233967 ! Control kit,hepatit | Medical Supply Chain | $75 |
About Orasure Technologies Inc.
Orasure Technologies Inc., doing business as Orasure, is a for-profit medical diagnostic products manufacturer headquartered in Bethlehem, Pennsylvania. The company specializes in developing, manufacturing, and marketing oral fluid diagnostic products and specimen collection devices, with a significant focus on providing medical testing solutions to federal government agencies. Orasure's product portfolio includes rapid diagnostic tests for various medical conditions, including HIV, Hepatitis, Ebola, COVID-19, and alcohol detection, making it a critical supplier of medical testing technologies to multiple federal agencies.
Through federal contract awards, Orasure has consistently provided a wide range of diagnostic test kits to various government agencies, primarily the Defense Logistics Agency Troop Support Medical. The company's contract awards have been predominantly for COVID-19 rapid tests, hepatitis control kits, HIV test kits, and alcohol detection tests. These contracts have ranged from small purchase orders of less than $100 to substantial delivery orders exceeding $50 million. No set-aside designations were typically used in these contract awards, indicating Orasure competed for these contracts through standard procurement processes. The majority of these contracts were fixed-price purchase orders or delivery orders, with the National Interest Action Code for Coronavirus COVID-19 being frequently referenced, particularly during the pandemic response period.
Regarding federal grant awards, Orasure has been involved in sub-grant activities focused on public health initiatives. Notable sub-grant awards include a partnership with the Maine Department of Health and Human Services for HIV, sexually transmitted diseases, and hepatitis screening tests targeting uninsured and high-risk individuals. Another significant sub-grant was with Emory University for a project titled "TOGETHER TAKEMEHOME," which appears to be focused on improving access to mailed HIV self-testing. These grant activities demonstrate Orasure's commitment to expanding access to critical medical diagnostic technologies and supporting public health screening efforts.
Orasure holds two significant federal contract Indefinite Delivery Vehicles (IDVs). The first is a single-award Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at $107.28 million and running through November 2023, which covers COVID-19 rapid tests and diagnostic tests for various medical conditions. The second is a multiple-award Federal Supply Schedule contract under GSA Schedule FSS-65-VII for Invitro Diagnostics, Reagents, and Test Kits, valued at $6.38 million and running through January 2027. These IDVs enable government agencies like the Department of Veterans Affairs and Defense Health Agency to efficiently procure Orasure's diagnostic products, including COVID-19 rapid tests, HIV test kits, and other medical diagnostic supplies.
Contract vehicles
Quick answers
What is Orasure Technologies Inc.'s UEI?
Orasure Technologies Inc.'s Unique Entity ID (UEI) in SAM.gov is Y79RWFLHWDM6.
What is Orasure Technologies Inc.'s CAGE code?
Orasure Technologies Inc.'s CAGE code is 0PNX6.
What is Orasure Technologies Inc.'s primary NAICS code?
Orasure Technologies Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).
Where is Orasure Technologies Inc. located?
Orasure Technologies Inc.'s physical address in SAM.gov is 220 E 1st St, Bethlehem, PA 18015, USA.
Is Orasure Technologies Inc. registered in SAM.gov?
Yes. Orasure Technologies Inc.'s SAM.gov registration is active through February 24, 2027.
Which contract vehicles does Orasure Technologies Inc. hold?
Orasure Technologies Inc. holds a place on 1 federal contract vehicle: FSS-65-VII.
What is Orasure Technologies Inc.'s most recent federal award?
Orasure Technologies Inc.'s most recent federal contract award is 8511361010 ! Control kit,hepatit (SPE2DS25P0912), from Medical Supply Chain, on May 8, 2025.
On GovTribe
See Orasure Technologies Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors